- PMID: 33810774
- DOI: 10.1080/07391102.2021.1905556
Abstract
Coronavirus (SARS-CoV-2), the causative agent of the Covid-19 pandemic has proved itself as the deadliest pathogen. A major portion of the population has become susceptible to this strain. Scientists are pushing their limits to formulate a vaccine against Covid-19 with the least side effects. Although the recent discoveries of vaccines have shown some relief from the covid infection rate, however, physical fatigue, mental abnormalities, inflammation and other multiple organ damages are arising as post-Covid symptoms. The long-term effects of these symptoms are massive. Patients with such symptoms are known as long-haulers and treatment strategy against this condition is still unknown. In this study, we tried to explore a strategy to deal with the post-Covid symptoms. We targeted three human proteins namely ACE2, Interleukin-6, Transmembrane serine protease and NRP1 which are already reported to be damaged via Covid-19 proteins and upregulated in the post-Covid stage. Our target plant in this study is Cannabis (popularly known as ‘Ganja’ in India). The molecular docking and simulation studies revealed that Cannabidiol (CBD) and Cannabivarin (CVN) obtained from Cannabis can bind to post-Covid symptoms related central nervous system (CNS) proteins and downregulate them which can be beneficial in post-covid symptoms treatment strategy. Thus we propose Cannabis as an important therapeutic plant against post-Covid symptoms.Communicated by Ramaswamy H. Sarma.
Keywords: Cannabis, Covid19, docking and molecular simulation, post-Covid neural degeneration, post-Covid symptoms
Similar articles
-
Ann Clin Lab Sci. 2022 May;52(3):511-525.PMID: 35777803 No abstract available.
-
Aging (Albany NY). 2020 Nov 22;12(22):22425-22444. doi: 10.18632/aging.202225. Epub 2020 Nov 22.PMID: 33221759 Free PMC article.
-
Molecules. 2022 Apr 27;27(9):2797. doi: 10.3390/molecules27092797.PMID: 35566148 Free PMC article.
-
J Biomol Struct Dyn. 2022 Aug;40(12):5665-5686. doi: 10.1080/07391102.2021.1873185. Epub 2021 Jan 18.PMID: 33459176
-
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19.
Int J Mol Sci. 2021 Feb 17;22(4):1986. doi: 10.3390/ijms22041986.PMID: 33671463 Free PMC article. Review.
Cited by
-
Neurological Consequences, Mental Health, Physical Care, and Appropriate Nutrition in Long-COVID-19.
Cell Mol Neurobiol. 2022 Sep 14:1-11. doi: 10.1007/s10571-022-01281-w. Online ahead of print.PMID: 36103031 Free PMC article. Review. -
Int J Mol Sci. 2022 Jun 6;23(11):6350. doi: 10.3390/ijms23116350.PMID: 35683028 Free PMC article. Review.
-
Life Sci. 2022 Jul 15;301:120624. doi: 10.1016/j.lfs.2022.120624. Epub 2022 May 11.PMID: 35568225 Free PMC article.
-
Cells. 2022 Apr 11;11(8):1298. doi: 10.3390/cells11081298.PMID: 35455977 Free PMC article.
-
ESCMID rapid guidelines for assessment and management of long COVID.
Clin Microbiol Infect. 2022 Jul;28(7):955-972. doi: 10.1016/j.cmi.2022.02.018. Epub 2022 Feb 17.PMID: 35182760 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut – more resources
-
Full Text Sources
-
Other Literature Sources
-
Miscellaneous